Boston Scientific Corporation
BSX
$48.31
-$0.80-1.63%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.57% | 4.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.57% | 4.36% | |||
| Cost of Revenue | -0.74% | 5.15% | |||
| Gross Profit | -1.93% | 4.02% | |||
| SG&A Expenses | -2.89% | 5.34% | |||
| Depreciation & Amortization | 1.75% | 1.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.69% | 5.73% | |||
| Operating Income | 2.98% | -0.86% | |||
| Income Before Tax | 66.14% | -25.37% | |||
| Income Tax Expenses | -686.67% | -83.61% | |||
| Earnings from Continuing Operations | 99.85% | -11.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -- | |||
| Net Income | 99.55% | -10.99% | |||
| EBIT | 2.98% | -0.86% | |||
| EBITDA | 1.21% | 1.01% | |||
| EPS Basic | 99.27% | -11.05% | |||
| Normalized Basic EPS | -1.03% | 8.06% | |||
| EPS Diluted | 99.96% | -11.66% | |||
| Normalized Diluted EPS | -0.83% | 8.11% | |||
| Average Basic Shares Outstanding | 0.15% | 0.07% | |||
| Average Diluted Shares Outstanding | -0.05% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||